Narrowband UVB and cream psoralen-UVA combination therapy for plaque-type psoriasis

M. Grundmann-Kollmann(Goethe University Frankfurt), Maurizio Podda(Goethe University Frankfurt), Thomas M. Zollner(Bayer (Germany)), Wolf‐­Henning Boehncke(University Hospital of Geneva), Roland Kaufmann(Robert Koch Institute), Falk Ochsendorf(University Hospital Frankfurt), Jean Krutmann(Leibniz Institute of Environmental Medicine), Diamant Thaçi(University of Lübeck), Ralf J. Ludwig(University of Lübeck)
Journal of the American Academy of Dermatology
April 26, 2004
10.1016/s0190-9622(03)00792-8
Cited by 62

Related Papers

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
|The Lancet|2015|566
Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition
|BMC Cancer|2012|561
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
|The Lancet|2021|538
European Evidence‐based (S3) Guidelines for the Treatment of Acne
|Journal of the European Academy of Dermatology and Venereology|2012|422